These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 1703555)
1. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein]. Shinoda I Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2627-39. PubMed ID: 1703555 [TBL] [Abstract][Full Text] [Related]
3. [Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)]. Tsukamoto T; Kumamoto Y; Yamazaki K; Umehara T; Miyao N; Ohmura K; Iwazawa M Hinyokika Kiyo; 1988 Jun; 34(6):987-95. PubMed ID: 2464917 [TBL] [Abstract][Full Text] [Related]
4. [Clinical study of tumor markers in prostatic cancer]. Ishihara Y; Fukagai T; Ohta K; Hiromoto Y; Hiramori M; Torii T; Higaki Y; Imamura K Hinyokika Kiyo; 1990 Apr; 36(4):425-31. PubMed ID: 1696063 [TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein]. Yoshiki T; Okada K; Oishi K; Yoshida O Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559 [TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer]. Arai Y; Yoshki T; Okada K; Yoshida O; Yamamoto N; Sakatoku J; Sugimura Y; Kawamura J Hinyokika Kiyo; 1989 Sep; 35(9):1519-28. PubMed ID: 2479237 [TBL] [Abstract][Full Text] [Related]
7. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers]. Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006 [TBL] [Abstract][Full Text] [Related]
8. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer]. Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588 [TBL] [Abstract][Full Text] [Related]
9. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer]. Watanabe M; Kitamura Y; Komatsubara S; Sakata Y Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542 [TBL] [Abstract][Full Text] [Related]
10. [Prostate specific antigen in serum of the patients with prostatic cancer]. Akimoto S; Akakura K; Fuse H; Shimazaki J Hinyokika Kiyo; 1988 Apr; 34(4):636-42. PubMed ID: 2456678 [TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer]. Park YC; Kiwamoto H; Nishioka T; Tsujihashi H; Mitsubayashi S; Matsuura T; Akiyama T; Kurita T; Miyamoto T Hinyokika Kiyo; 1987 Jun; 33(6):883-8. PubMed ID: 2445188 [TBL] [Abstract][Full Text] [Related]
12. [Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases]. Uchijima Y; Yoshida K; Saitoh H Hinyokika Kiyo; 1991 Oct; 37(10):1255-60. PubMed ID: 1721770 [TBL] [Abstract][Full Text] [Related]
13. Serum gamma-seminoprotein determination in prostatic cancer. Shimazaki J; Akimoto S; Akakura K; Yoshiki T; Yoshida O; Okada K; Matsuoka K; Noda S; Eto K Hinyokika Kiyo; 1991 Apr; 37(4):341-7. PubMed ID: 1716404 [TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma]. Sugimura Y; Sakurai M; Hioki T; Hayashi N; Yamakawa K; Tajima K; Tochigi H; Kawamura J Hinyokika Kiyo; 1988 Dec; 34(12):2129-34. PubMed ID: 2467541 [TBL] [Abstract][Full Text] [Related]
15. [Relationship between reactivation and tumor markers in prostatic cancer]. Fuse H; Umeda K; Kazama T; Sakamoto M; Sakai T; Fujishiro Y; Mizuno I; Katayama T Hinyokika Kiyo; 1991 Jan; 37(1):39-43. PubMed ID: 1707217 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer]. Akimoto S; Akakura K; Shimazaki J Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543 [TBL] [Abstract][Full Text] [Related]
17. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer]. Sakai N; Ogawa T; Ishibashi Y; Fukuoka H; Sakanishi S Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409 [TBL] [Abstract][Full Text] [Related]
18. [Measurements of prostatic acid phosphatase and prostate specific antigen by fully automated enzyme immunoassay system--its analytical and clinical evaluation]. Matui A; Yamada T; Sugita O; Yakata M Rinsho Byori; 1990 Jun; 38(6):693-8. PubMed ID: 1696328 [TBL] [Abstract][Full Text] [Related]
19. Two prostate-specific antigens, gamma-seminoprotein and beta-microseminoprotein. Hara M; Kimura H J Lab Clin Med; 1989 May; 113(5):541-8. PubMed ID: 2654306 [TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of serum gamma-seminoprotein in patients with prostatic cancer]. Ishihara Y; Hiromoto Y; Higaki Y; Imamura K Hinyokika Kiyo; 1989 Mar; 35(3):409-13. PubMed ID: 2660507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]